ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1072

CCR2+ Circulating Monocytes Contribute to the Survival of ADSC in Bleomycin-Induced Skin Fibrosis

Madhavi Latha Chalasani1, Liyoung Kim 1 and Theresa Lu 2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine (Microbiology and Immunology), New York

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: ADSC and monocytes, Skin fibrosis, Systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Monocytes and monocyte-derived cells play a crucial role during homeostasis and also during the development of various inflammatory diseases including skin fibrosis. Ly6Chi inflammatory monocytes formed in the bone marrow enter the circulation as mature C-C Chemokine Receptor 2 (CCR2+) cells and exert their function by their ability to differentiate into macrophages and other myeloid cell types in the peripheral tissues. Our lab previously showed upregulation of monocytes and monocyte derived macrophages followed by loss of adipose-derived stromal cells (ADSC) in bleomycin-induced skin fibrosis. CCR2 is implicated to have a pathogenic role in multiple fibrosis models.  Here, we hypothesized that CCR2+ monocytes that infiltrate the skin following bleomycin treatment play an important role in modulating ADSC maintenance and bleomycin-induced skin fibrosis changes.

Methods: C57BL/6J wild type (WT) and CCR2 knockout (CCR2KO) mice were injected with either PBS (control) or 100ug of bleomycin subcutaneously on the lower back skin for indicated time periods. Skin was assessed for cellular changes by flow cytometry and for fibrotic changes by H&E staining followed by dermal and dermal white adipose tissue (DWAT) thickness measurements.

Results: Consistent with the idea that monocyte accumulation in skin is dependent on CCR2 and that the macrophages are monocyte-derived, we observed a robust increase in monocytes and monocyte-derived macrophages in WT but not CCR2KO mice at day 21 after bleomycin treatment. Contrary to expectations, however, while bleomycin-treated WT mice showed ~55% reduction in ADSC numbers compared to PBS control, CCR2KO mice under the same conditions showed further severity in ADSC loss (~80% reduction). CCR2 KO mice also showed increased dermal thickness without further loss of DWAT compared to bleomycin-treated WT mice. These results suggest a role for CCR2+ cells, potentially monocytes and monocyte-derived macrophages, in maintaining ADSC numbers and limiting fibrosis in bleomycin-induced skin fibrosis.

Conclusion: Our results thus far suggest a protective role for CCR2, potentially by mediating the accumulation of monocytes and macrophages and maintaining ADSC numbers during bleomycin-induced skin fibrosis. Further studies will focus on establishing the role of CCR2-dependent monocytes versus CCR2 on other cell populations as well as on understanding the mechanism by which CCR2 regulates ADSC populations. These results could thus help in better understanding and therapeutic targeting of the disease.


Disclosure: M. Chalasani, None; L. Kim, None; T. Lu, None.

To cite this abstract in AMA style:

Chalasani M, Kim L, Lu T. CCR2+ Circulating Monocytes Contribute to the Survival of ADSC in Bleomycin-Induced Skin Fibrosis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/ccr2-circulating-monocytes-contribute-to-the-survival-of-adsc-in-bleomycin-induced-skin-fibrosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ccr2-circulating-monocytes-contribute-to-the-survival-of-adsc-in-bleomycin-induced-skin-fibrosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology